eIF4G2/p97 Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F1432-20UL

Regular price €169,00 EUR
Regular price Sale price €169,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

eIF4G2/p97 is a target of interest in many antibody-based workflows. eIF4G2, also known as p97, NAT1, and DAP5, is a member of the eIF4G protein family, which includes the major isoform eIF4GI (EIF4G1), the least-expressed isoform eIF4GII (EIF4G3), and eIF4G2 (EIF4G2). eIF4G2 is a 97-kDa protein homologous to the C-terminal two-thirds of eIF4GI, produced by picornaviral proteolysis. It is a novel target for mRNA editing by Apobec-1, which has RNA-binding and cytidine deaminase activities. eIF4G2 plays a crucial role in apoptosis, cell survival, differentiation, and embryonic development by activating the translation of key proteins. Depending on the literature source, eIF4G2/p97 may also be discussed as eIF4G2/p97.

Reported cellular context includes adherens junction, axon, and cytosol, which can matter when signal is compared across treatments or changing cell states. Following eIF4G2/p97 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

eIF4G2/p97 is commonly interpreted in the context of developmental biology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans adherens junction, axon, and cytosol, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between adherens junction, axon, and cytosol across matched conditions
  • stage-dependent patterns during differentiation, morphogenesis, or lineage commitment
  • co-patterning with orthogonal markers and control conditions that clarify pathway state
  • time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for eIF4G2/p97. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in eIF4G2/p97 reflect biology rather than handling. When interpreting eIF4G2/p97, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep eIF4G2/p97 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
EIF4G2 • P97
Research Area:
Developmental Biology
Application:
FCM • IF • IP • WB
Reactivity:
Human • Monkey • Mouse • Rat
Specificity:
eIF4G2/p97 Antibody [P17K12] detects endogenous levels of total eIF4G2/p97 protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
P17K12
UniProt:
P78344
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.